Rolando Herrero

Time course and determinants of the antibody response to SARS-CoV-2 in Costa Rica: the RESPIRA study

A population-based case–control study of COVID-19: methodological considerations on the role of testing bias

SARS-CoV-2 antibody and neutralization dynamics among persons with natural- and vaccine-induced exposures

Cervical Cancer Screening and Treatment Algorithms Using Human Papillomavirus Testing-Lessons Learnt from a South African Pilot Randomized Controlled Trial.

Supplementary Table 2 from Cervical Cancer Screening and Treatment Algorithms Using Human Papillomavirus Testing—Lessons Learnt from a South African Pilot Randomized Controlled Trial

Supplementary Table 1 from Cervical Cancer Screening and Treatment Algorithms Using Human Papillomavirus Testing—Lessons Learnt from a South African Pilot Randomized Controlled Trial

Data from Cervical Cancer Screening and Treatment Algorithms Using Human Papillomavirus Testing—Lessons Learnt from a South African Pilot Randomized Controlled Trial

Supplementary Table 2 from Cervical Cancer Screening and Treatment Algorithms Using Human Papillomavirus Testing—Lessons Learnt from a South African Pilot Randomized Controlled Trial

Data from Cervical Cancer Screening and Treatment Algorithms Using Human Papillomavirus Testing—Lessons Learnt from a South African Pilot Randomized Controlled Trial

Supplementary Table 1 from Cervical Cancer Screening and Treatment Algorithms Using Human Papillomavirus Testing—Lessons Learnt from a South African Pilot Randomized Controlled Trial

Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: an analysis within the ESTAMPA study

Performance of standardised colposcopy to detect cervical precancer and cancer for triage of women testing positive for human papillomavirus: results from the ESTAMPA multicentric screening study

Reproducible and clinically translatable deep neural networks for cervical screening

Cohort profile: evaluation of immune response and household transmission of SARS-CoV-2 in Costa Rica: the RESPIRA study

Estimating the cumulative incidence of SARS-CoV-2 infection in Costa Rica: modelling seroprevalence data in a population-based cohort

Comparing one dose of HPV vaccine in girls aged 9–14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial

molBV reveals immune landscape of bacterial vaginosis and predicts human papillomavirus infection natural history

Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines: World Health Organization consultations, October 2021—March 2022

Risk factors for head and neck cancer in more and less developed countries: Analysis from the INHANCE consortium

Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer

Infection with Human Papilloma Virus (HPV) and risk of subsites within the oral cancer

Reproducibility, Temporal Variability, and Concordance of Serum and Fecal Bile Acids and Short Chain Fatty Acids in a Population-Based Study.

Cervicovaginal microbiome and natural history of HPV in a longitudinal study

Alcohol drinking and head and neck cancer risk: the joint effect of intensity and duration

Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial

Evaluation of serological assays to monitor antibody responses to single-dose HPV vaccines

Cognitions and behaviours of general practitioners in France regarding HPV vaccination: A theory-based systematic review

Regional variations in Helicobacter pylori infection, gastric atrophy and gastric cancer risk: The ENIGMA study in Chile.

Reproducibility of a Rapid Human Papillomavirus Test at Different Levels of the Healthcare System in Tanzania: The AISHA Study.

Germline Determinants of Humoral Immune Response To HPV-16 Protect Against Oropharyngeal Cancer